Promotion of endometriosis in mice by polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls

Environmental Health Perspectives

Volumn 105, Issue 7, 1997, Pages 750-755

  Johnson, Krista L ^a   Cummings, Audrey M ^b   Birnbaum, Linda S ^b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Endometriosis; Halogenated aromatic hydrocarbon; Polychlorinated biphenyls; Polychlorinated dibenzo p dioxins; Polychlorinated dibenzofurans; Structure activity relationships; TCDD

Indexed keywords

AROMATIC HYDROCARBON; AROMATIC HYDROCARBON RECEPTOR; ETHOXYRESORUFIN DEETHYLASE; POLYCHLORINATED BIPHENYL; POLYCHLORINATED DIBENZODIOXIN; POLYCHLORINATED DIBENZOFURAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENDOMETRIOSIS; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; LIVER; MOUSE; NONHUMAN; OVARY; PRIORITY JOURNAL; THYMUS; TOXICITY; UTERUS HORN;

EID: 0030867327     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.97105750     Document Type: Article

References (37)

1. Safe S. Polychlorinaced biphenyls (PCBs), dibenzo-p-dioxin (PCDDs), dibenzofurans (PCDFs), and related compounds: environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs). Crit Rev Toxicol 21:51-74 (1990).
2. Safe S, Hutzinger O. PCDDs and PCDFs: sources and environmental impact. In: Environmental Toxin Series, vol 3. Heidelberg, Germany:Springer Verlag, 1990;2-20.
3. Birnbaum LS, DeVito MJ. Use of toxic equivalency factors for risk assessment for dioxins and related compounds. Toxicology 105:391-401 (1995).
4. Birnbaum LS. The mechanism of dioxin toxicity: relationship to risk assessment. Environ Health Perspect 102(suppl 9):157-167 (1994).
5. Kociba RJ, Keller PA, Park CN, Gehring PJ. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD): results of a 13-week oral toxicity study in rats. Toxicol Appl Pharmacol 35:553-574 (1976).
6. Barsotti DA, Abrahamson LJ, Allen JR. Hormonal alterations in female rhesus monkeys fed a diet containing 2,3,7,8-tetrachlorodibenzo-p-dioxin. Bull Environ Contam Toxicol 211:463-469 (1979).
7. Umbreit TH, Hesse EJ, Macdonald GJ, Gallo MA. Effects of TCDD-estradiol interactions in three strains of mice. Toxicol Lett 40:1-9 (1987).
8. Rier SE, Martin DC, Bowman RE, Dmowski WP, Becker JL. Endometriosis in rhesus monkeys (Macaca mulatta) following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fundam Appl Toxicol 21:433-441 (1993).
9. Cummings AM, Metcalf JL, Birnbaum L. Promotion of endometriosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats and mice: time-dose dependence and species comparison. Toxicol Appl Pharmacol 138:131-139 (1996).
10. Olive DL, Schwartz LB. Endometriosis. New Engl J Med 328:1759-1769 (1993).
11. Brosens I, Vasquez G, Deprest J, Puttemans P. Pathogenesis of endometriosis. In: Endometriosis: Advanced Management and Surgical Techniques (Nezhat CR, Berger GS, Nezhat FR, Buttram VCJ, Nezhat CH, eds). New York:Springer-Verlag, 1995;9-17.
12. Cummings AM, Metcalf JL. Induction of endometriosis in mice: a new model sensitive to estrogen. Reprod Toxicol 9:233-238 (1995).
13. Dmowski WP, Braun D, Gebel H. The immune system in endometriosis. In: Modern Approaches to Endometriosis (Thomas EJ, Rock JA, eds). Boston:Kluwer Academic, 1991;97-111.
14. Lundberg K, Dencker L, Grovnik K-O. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) inhibits the activation of antigen-specific T-cells in mice. Int J Immunopharmacol 14:699-705 (1992).
15. Berger GS. Epidemiology of endometrosis. In: Endometriosis: Advanced Management and Surgical Techniques (Nezhat CR, Berger GS, Nezhat FR, Buttram VCJ, Nezhat CH, eds). New York:Springer-Verlag, 1995;3-7.
16. Koninckx PR, Meuleman C, Demeyere S, Lesaffre E, Cornillie F. Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain. Ferril Steril 55:759-765 (1991).
17. Koninckx PR, Braet P, Kennedy SH, Barlow DH. Dioxin pollution and endometriosis in Belgium. Hum Reprod 9:1001-1002 (1994).
18. Mayani A, Barel S, Soback S, Almagor M. Dioxin levels in women with endometriosis. Hum Reprod 12:373-375 (1997).
19. DeVito MJ, Birnbaum LS. The importance of pharmacokinetics in determining the relative potency of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 2,3,7,8-tetrachlorodibenzofuran. Fundam Appl Toxicol 24:145-148 (1995).
20. Hanson CD, Smialowicz RJ. Evaluation of the effect of low-level 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on cell mediated immunity. Toxicology 88:213-224 (1994).
21. Vernon MW, Wilson EA. Studies on the surgical induction of endometriosis in the rat. Fertil Steril 44:684-694 (1985).
22. Diliberto JJ, Akubue PI, Luebke RW, Birnbaum LS. Dose-response relationships of tissue distribution and induction of CYP1A1 and CYP1A2 enzymatic activities following acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice. Toxicol Appl Pharmacol 130:197-208 (1995).
23. Bradfofd MM. A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254 (1976).
24. Okey AB, Riddick DS, Harper PA. Molecular biology of the aromatic hydrocarbon (dioxin) receptor. TIPS 15:226-232 (1994).
25. Safe S. Comparative toxicology and mechanism of action of polychlorinated dibenzo-p-dioxins and dibenzofurans. Ann Rev Pharmacol Toxicol 26:371-379 (1986).
26. Mason G, Farell K, Keys B, Piskorska-Pliszczynska J, Safe L, Safe S. Polychlorinated dibenzo-p-dioxins: quantitative in vitro and in vivo structure-activity relationships. Toxicology 41:21-31 (1986).
27. Bandiera S, Sawyer T, Romkes M, Zmudzka B, Safe L, Mason G, Keys B, Safe S. Competitive binding to the cytosolic 2,3,7,8-TCDD receptor: effects of structure on the affinities of substituted halogenated biphenyls - a QSAR approach. Biochem Pharmacol 32:3803-3813 (1983).
28. Kafafi SA, Afeefy HY, Said HK, Hakimi JM. A new structure-activity model for Ah receptor binding. Polychlorinated dibenzo-p-dioxins and dibenzofurans. Chem Res Toxicol 5:856-862 (1992).
29. Brewster DW, Birnbaum LS. Disposition and excretion of 2,3,4,7,8-pentachlorodibenzofuran (4-PeCDF) in the rat. Toxicol Appl Pharmacol 90:243-252 (1987).
30. Li X, Johnson DC, Rozman KK. Reproductive effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in female rats: ovulation, hormonal regulation and possible mechanisms. Toxicol Appl Pharmacol 133:321-327 (1995).
31. Cummings AM, Metcalf JL. Effects of estrogen, progesterone, and methoxychlor on surgically induced endometriosis in rats. Fundam Appl Toxicol 27:287-290 (1995).
32. DeVito MJ, Birnbaum LS. Toxicology of dioxins and related chemicals. In: Dioxins and Health (Schecter A, ed). New York:Plenum Press, 1994;139-162.
33. DeVito MJ, Thomas T, Martin E, Umbreit TH, Gallo MA. Antiestrogenic action of 2,3,7,8-terrachlorodibenzo-p-dioxin: tissue-specific regulation of estrogen receptor in CD1 mice. Toxicol Appl Pharmacol 113:1-9 (1992).
34. Pohjanvirta R, Tuomisto J. Short-term toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals: effects, mechanisms, and animal models. Pharmacol Rev 46:483-549 (1994).
35. Whitlock JPJ. Genetic and molecular aspects of 2,3,7,8-tetrachlorodibenzo-p-dioxin action. Ann Rev Pharmacol Toxicol 30:251-277 (1990).
36. Poland A, Glover E. Comparison of 2,3,7,8-tetrachlorodibenzo-p-dioxin, a potent inducer of aryl hydrocarbon hydroxylase, with 3-methylcholanthrene. Mol Pharmacol 10:349-359 (1974).
37. Goldstein JA, Weacer R, Sundheimer DW. Metabolism of 2-acetylaminofluorene by two 3-methylcholanthrene inducible forms of rat liver cytochrome P-450. Cancer Res 44:3768-3771 (1984).